AI Article Synopsis

  • Researchers used mass spectrometry to detect an intact protein-drug complex in rat liver tissue after the rats were given the drug bezafibrate.
  • The complex involved fatty acid binding protein 1 (FABP1) non-covalently bonded with bezafibrate.
  • This study represents the first successful analysis of non-covalent protein-drug complexes, which could significantly aid early drug discovery by allowing for direct characterization in a physiological context.

Article Abstract

Here, we demonstrate detection by mass spectrometry of an intact protein-drug complex directly from liver tissue from rats that had been orally dosed with the drug. The protein-drug complex comprised fatty acid binding protein 1, FABP1, non-covalently bound to the small molecule therapeutic bezafibrate. Moreover, we demonstrate spatial mapping of the [FABP1+bezafibrate] complex across a thin section of liver by targeted mass spectrometry imaging. This work is the first demonstration of mass spectrometry analysis of a non-covalent protein-drug complex formed and has implications for early stage drug discovery by providing a route to target-drug characterization directly from the physiological environment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10946869PMC
http://dx.doi.org/10.1002/ange.202202075DOI Listing

Publication Analysis

Top Keywords

mass spectrometry
16
protein-drug complex
16
non-covalent protein-drug
8
orally dosed
8
complex
5
mass
4
spectrometry detection
4
detection imaging
4
imaging non-covalent
4
protein-drug
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!